These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30202013)

  • 1. Heterogeneity of cannabinoid ligand-induced modulations in intracellular Ca
    Xia KK; Shen JX; Huang ZB; Song HM; Gao M; Chen DJ; Zhang SJ; Wu J
    Acta Pharmacol Sin; 2019 Mar; 40(3):410-417. PubMed ID: 30202013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells.
    Huang Z; Wang H; Wang J; Zhao M; Sun N; Sun F; Shen J; Zhang H; Xia K; Chen D; Gao M; Hammer RP; Liu Q; Xi Z; Fan X; Wu J
    Sci Rep; 2016 Jul; 6():29757. PubMed ID: 27432473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
    Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
    Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
    Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB1 and CB2 receptors differentially modulate L- and T-type Ca
    Qian WJ; Yin N; Gao F; Miao Y; Li Q; Li F; Sun XH; Yang XL; Wang Z
    Neuropharmacology; 2017 Sep; 124():143-156. PubMed ID: 28431968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function.
    Vilches-Flores A; Hauge-Evans AC; Jones PM; Persaud SJ
    Clin Sci (Lond); 2013 Apr; 124(7):467-78. PubMed ID: 23078523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.
    Yrjölä S; Sarparanta M; Airaksinen AJ; Hytti M; Kauppinen A; Pasonen-Seppänen S; Adinolfi B; Nieri P; Manera C; Keinänen O; Poso A; Nevalainen TJ; Parkkari T
    Eur J Pharm Sci; 2015 Jan; 67():85-96. PubMed ID: 25447744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
    Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of cannabinoid CB
    Ma Z; Gao F; Larsen B; Gao M; Luo Z; Chen D; Ma X; Qiu S; Zhou Y; Xie J; Xi ZX; Wu J
    EBioMedicine; 2019 Apr; 42():225-237. PubMed ID: 30952618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
    Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB
    González-Mariscal I; Carmona-Hidalgo B; Winkler M; Unciti-Broceta JD; Escamilla A; Gómez-Cañas M; Fernández-Ruiz J; Fiebich BL; Romero-Zerbo SY; Bermúdez-Silva FJ; Collado JA; Muñoz E
    Pharmacol Res; 2021 Jul; 169():105492. PubMed ID: 34019978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid signalling inhibits sarcoplasmic Ca
    Oláh T; Bodnár D; Tóth A; Vincze J; Fodor J; Reischl B; Kovács A; Ruzsnavszky O; Dienes B; Szentesi P; Friedrich O; Csernoch L
    J Physiol; 2016 Dec; 594(24):7381-7398. PubMed ID: 27641745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of primary sensory neurone cannabinoid type-1 receptors in pain and the analgesic effects of the peripherally acting agonist CB-13 in mice.
    Ford NC; Barpujari A; He SQ; Huang Q; Zhang C; Dong X; Guan Y; Raja SN
    Br J Anaesth; 2022 Jan; 128(1):159-173. PubMed ID: 34844727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites.
    Yang YY; Hsieh SL; Lee PC; Yeh YC; Lee KC; Hsieh YC; Wang YW; Lee TY; Huang YH; Chan CC; Lin HC
    J Hepatol; 2014 Nov; 61(5):1004-13. PubMed ID: 24953022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve Ligation-Induced Pain in Rats.
    Shiue SJ; Peng HY; Lin CR; Wang SW; Rau RH; Cheng JK
    Reg Anesth Pain Med; 2017; 42(4):499-506. PubMed ID: 28492437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
    Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
    Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB
    Li AL; Carey LM; Mackie K; Hohmann AG
    J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
    Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Ethanol Inhibition of Adult Hippocampal Neurogenesis Involves CB1 Cannabinoid Receptor Signaling.
    Khatri D; Laroche G; Grant ML; Jones VM; Vetreno RP; Crews FT; Mukhopadhyay S
    Alcohol Clin Exp Res; 2018 Apr; 42(4):718-726. PubMed ID: 29417597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.
    Köfalvi A; Lemos C; Martín-Moreno AM; Pinheiro BS; García-García L; Pozo MA; Valério-Fernandes Â; Beleza RO; Agostinho P; Rodrigues RJ; Pasquaré SJ; Cunha RA; de Ceballos ML
    Neuropharmacology; 2016 Nov; 110(Pt A):519-529. PubMed ID: 26976670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.